Brief: Codexis Reports Unaudited Pro Forma Cash And Cash Equivalents Of $70 Million As Of December 31, 2023
09/01/2024 14:43
Jan 9 (Reuters) - Codexis Inc CDXS.O :
* CODEXIS INC - REPORTED UNAUDITED PRO FORMA CASH AND CASH
EQUIVALENTS OF APPROXIMATELY $70 MILLION AS OF DECEMBER 31, 2023
* CODEXIS- CONTINUES TO EXPECT EXISTING CASH,CASH
EQUIVALENTS WILL
BE SUFFICIENT TO FUND PLANNED OPERATIONS TO POSITIVE CASH FLOW,
EXPECTED AROUND END OF 2026
* CODEXIS-PRODUCT REVENUES FOR 2023 EXPECTED TO BE TOWARD
UPPER
END OF GUIDANCE RANGE OF $30 MILLION TO $35 MILLION, EXCLUDING
ENZYME SALES RELATED TO PAXLOVID
Further company coverage: CDXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codexis
See all newsCodexis, Inc. reports results for the quarter ended June 30 - Earnings Summary
Codexis Q2 net loss narrows, helped by lower operating expenses
Codexis, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor